Rex L. Williams, Ph.D., has more than 20 years of experience in life sciences spanning molecular biology, DMPK, and clinical and nonclinical pharmacology. Dr. Williams has contributed to and led the application of clinical pharmacology and pharmacometrics across all phases of drug development.

Dr. Williams previously served as Vice President of Clinical Pharmacology at SpringWorks Therapeutics where he oversaw clinical pharmacology, pharmacometrics, DMPK, and bioanalysis efforts for the clinical stage portfolio in rare oncology leading to multiple regulatory submissions and drug approvals. Before SpringWorks, Dr. Williams was a clinical pharmacologist at Bausch Health and a clinical pharmacology consultant and program manager at Nuventra Pharma Sciences.

Dr. Williams holds a Ph.D. in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill and a B.S. in Biochemistry from Texas A&M University.